Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes
Anuhya Kommalapati(University of South Carolina), Gaurav Goyal(University of Alabama at Birmingham), Martin Durkin(Palmetto Health Richland), Ronald S. Go(Mayo Clinic), Sri Harsha Tella(University of South Carolina)
Cited by 133
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
|Journal of Clinical Oncology|1999|697
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
|Journal of Clinical Oncology|2012|682
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years
|Journal of Oncology Practice|2017|447